Both in Biotechnology
Scholar Rock Holding vs Immunovant
Over the past year SRRK returned +48.2% and IMVT returned +18.2%; their daily moves had a correlation of 0.33.
SRRK +48.2% IMVT +18.2%Growth of $1, one year, split-adjusted
| Metric | SRRK | IMVT |
|---|---|---|
| Price | $43.90 | $29.17 |
| Market cap | $5.35B | $6.03B |
| Today | −0.63% | −1.59% |
| 1 month | −4.9% | −13.3% |
| 6 months | −5.3% | +7.6% |
| Year to date | −0.3% | +14.8% |
| 1 year | +50.0% | +34.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $295.9M | $797.8M |
| Dividend yield | — | — |
| Volatility (60d) | 43.2% | 36.8% |
| Short % of float | 20.3% | 21.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).